Career Enhancement Program (CEP)

职业提升计划摘要 职业提升计划(CEP)的总体具体目标是：1)招聘和发展 致力于前列腺癌(PCA)转化研究的初级教员的职业生涯，以及2) 确定已经在另一个研究领域站稳脚跟的中高级调查人员，但 希望将他们的重点重新定向到PCA领域。以现有的优秀计划为基础，并 威尔·康奈尔医学院(WCM)在PCA翻译和临床研究方面的优秀资源 在哥伦比亚大学医学中心，我们的CEP旨在培养未来PCA研究的领导者。 通过严格的赠款遴选程序，我们的CEP咨询委员会(AC)将确定符合以下条件的候选人 最有潜力取得成功，并致力于PCA研究事业的人。咨询委员会成员 将向WCM孢子执行委员会提出资金建议，然后密切 监督所有获奖研究人员的进展，以确保该计划的研究目标， 教育、科学和拨款方面的写作都得到了满足。他们还将在以下方面提供积极的研究榜样 支持性的学术环境。CEP的最终目标是为获奖者提供 成功的临床、翻译和/或基础科学PCA研究所需的知识和工具 事业。在参与CEP的工作结束后，获奖者将能够设计和实施 假设驱动的PCA研究，获得同行评审拨款的能力显著提高 资金来自联邦或其他外部来源。 Douglas Scherr博士和Lorraine Gudas博士，他们都在指导和 发展初级教员的职业生涯，将监督CEP。作为CEP的一部分，我们还将教育和 在交叉协作中指导医生和实验室科学家，这将导致设计和 通过创建协作项目，在PCA中进行假设驱动的临床/转化性治疗研究 和富有成效的研究背景下的PCA孢子。

CAREER ENHANCEMENT PROGRAM SUMMARY The overall Specific Aim of the Career Enhancement Program (CEP) is to 1) recruit and develop the careers of junior faculty who are committed to translational research in prostate cancer (PCa), and to 2) identify mid- and senior-level investigators who are already established in another area of research, but want to redirect their focus to the field of PCa. Building on the already existing outstanding programs and excellent resources for translational and clinical research in PCa at Weill Cornell Medicine (WCM) and the Columbia University Medical Center, our CEP is designed to develop future leaders in PCa research. Using a rigorous grant selection process, our CEP Advisory Committee (AC), will identify candidates with the highest potential for success and who are committed to careers in PCa research. The AC members will make recommendations to the WCM SPORE's Executive Committee for funding and then closely monitor the progress of all awarded investigators to ensure that the Program's goals in research, education, and scientific and grant writing are met. They will also provide positive research role models in a supportive academic environment. The ultimate goal of the CEP is to provide awardees with the knowledge and tools necessary for successful clinical, translational, and/or basic science PCa research careers. At the conclusion of their involvement with the CEP, awardees will be able to design and conduct hypothesis-driven PCa research, with significantly increased abilities to obtain peer-reviewed grant funding from federal or other extramural sources. Drs. Douglas Scherr and Lorraine Gudas, each of who have extensive experience in mentoring and developing the career of junior faculty, will oversee the CEP. As part of the CEP, we will also educate and mentor physicians and laboratory-based scientists in cross collaborations that will lead to the design and conduct of hypothesis-driven clinical/translational therapeutic research in PCa by creating a collaborative and productive research setting within the PCa SPORE.